Consistent with that notion, certain RRM1 single nucleotide polymorphisms (SNPs) were reported to be associated with reduced ara‐CTP accumulation in ara‐C‐treated primary patient AML blasts, as well as worse survival (Cao et al, 2013). The gene discussed is RRM1; the disease is acute myeloid leukemia.